Annie Moradian

Annie Moradian

orcid

Research Focus & Metrics

Academic Career Length

37Years (1990-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
11 January 2021 in Nature Communications
Verified
Journal Article
Open access
PDF file
CSChun-Shik Shin
Chun-Shik Shin
SMShuxia Meng
Shuxia Meng
Spiros GarbisSpiros Garbis
Spiros Garbis
AMAnnie Moradian
Annie Moradian
RTRobert W. Taylor
Robert W. Taylor
DCDavid C. Chan
David C. Chan
Most mitochondrial precursor polypeptides are imported from the cytosol into the mitochondrion, where they must efficiently undergo folding. Mitochondrial precursors are imported as unfolded polypeptides. For proteins of the mitochondrial matrix and inner membrane, two separate chaperone systems, HSP60 and mitochondrial HSP70 (mtHSP70), facilitate protein folding. We show that LONP1, an AAA+ protease of the mitochondrial matrix, works with the mtHSP70 chaperone system to promote mitochondrial protein folding. Inhibition of LONP1 results in aggregation of a protein subset similar to that caused by knockdown of DNAJA3, a co-chaperone of mtHSP70. LONP1 is required for DNAJA3 and mtHSP70 solubility, and its ATPase, but not its protease activity, is required for this function. In vitro, LONP1 shows an intrinsic chaperone-like activity and collaborates with mtHSP70 to stabilize a folding intermediate of OXA1L. Our results identify LONP1 as a critical factor in the mtHSP70 folding pathway and demonstrate its proposed chaperone activity.

21 September 2020 in eLife
Verified
Journal Article
Open access
WIWilliam T Ireland
William T Ireland
SBSuzannah M Beeler
Suzannah M Beeler
EFEmanuel Flores-Bautista
Emanuel Flores-Bautista
NMNicholas S McCarty
Nicholas S McCarty
TRTom Röschinger
Tom Röschinger
RPRob Phillips
Rob Phillips
Advances in DNA sequencing have revolutionized our ability to read genomes. However, even in the most well-studied of organisms, the bacteriumEscherichia coli, for ≈65% of promoters we remain ignorant of their regulation. Until we crack this regulatory Rosetta Stone, efforts to read and write genomes will remain haphazard. We introduce a new method, Reg-Seq, that links massively parallel reporter assays with mass spectrometry to produce a base pair resolution dissection of more than aE. colipromoters in 12 growth conditions. We demonstrate that the method recapitulates known regulatory information. Then, we examine regulatory architectures for more than 80 promoters which previously had no known regulatory information. In many cases, we also identify which transcription factors mediate their regulation. This method clears a path for highly multiplexed investigations of the regulatory genome of model organisms, with the potential of moving to an array of microbes of ecological and medical relevance.

3 February 2020 in Analytical Chemistry
Verified
Journal Article
Closed access
CNCajetan Neubauer
Cajetan Neubauer
ACAntoine Crémière
Antoine Crémière
XWXingchen T. Wang
Xingchen T. Wang
NTNivedita Thiagarajan
Nivedita Thiagarajan
ASAlex L. Sessions
Alex L. Sessions
JEJohn M. Eiler
John M. Eiler

23 December 2019 in eLife
Verified
Journal Article
Open access
SHSpencer Hill
Spencer Hill
KRKurt Reichermeier
Kurt Reichermeier
DSDaniel C Scott
Daniel C Scott
LSLorena Samentar
Lorena Samentar
JCJasmin Coulombe-Huntington
Jasmin Coulombe-Huntington
GKGary Kleiger
Gary Kleiger
The cullin-RING ligases (CRLs) form the major family of E3 ubiquitin ligases. The prototypic CRLs in yeast, called SCF enzymes, employ a single E2 enzyme, Cdc34, to build poly-ubiquitin chains required for degradation. In contrast, six different human E2 and E3 enzyme activities, including Cdc34 orthologs UBE2R1 and UBE2R2, appear to mediate SCF-catalyzed substrate polyubiquitylation in vitro. The combinatorial interplay of these enzymes raises questions about genetic buffering of SCFs in human cells and challenges the dogma that E3s alone determine substrate specificity. To enable the quantitative comparisons of SCF-dependent ubiquitylation reactions with physiological enzyme concentrations, mass spectrometry was employed to estimate E2 and E3 levels in cells. In combination with UBE2R1/2, the E2 UBE2D3 and the E3 ARIH1 both promoted SCF-mediated polyubiquitylation in a substrate-specific fashion. Unexpectedly, UBE2R2 alone had negligible ubiquitylation activity at physiological concentrations and the ablation of UBE2R1/2 had no effect on the stability of SCF substrates in cells. A genome-wide CRISPR screen revealed that an additional E2 enzyme, UBE2G1, buffers against the loss of UBE2R1/2. UBE2G1 had robust in vitro chain extension activity with SCF, and UBE2G1 knockdown in cells lacking UBE2R1/2 resulted in stabilization of the SCF substrates p27 and CYCLIN E as well as the CUL2-RING ligase substrate HIF1α. The results demonstrate the human SCF enzyme system is diversified by association with multiple catalytic enzyme partners.

20 August 2024 in Journal of Proteome Research
Verified
Journal Article
Open access
NHNathan G. Hendricks
Nathan G. Hendricks
SBSantosh D. Bhosale
Santosh D. Bhosale
AKAngel J. Keoseyan
Angel J. Keoseyan
JOJosselin Ortiz
Josselin Ortiz
ASAleksandr Stotland
Aleksandr Stotland
JEJennifer Van Eyk
Jennifer Van Eyk
This Technical Note presents a comprehensive proteomics workflow for the new combination of Orbitrap and Astral mass analyzers across biofluids, cells, and tissues. Central to our workflow is the integration of Adaptive Focused Acoustics (AFA) technology for cells and tissue lysis to ensure robust and reproducible sample preparation in a high-throughput manner. Furthermore, we automated the detergent-compatible single-pot, solid-phase-enhanced sample Preparation (SP3) method for protein digestion. The synergy of these advanced methodologies facilitates a robust and high-throughput approach for cell and tissue analysis, an important consideration in translational research. This work disseminates our platform workflow, analyzes the effectiveness, demonstrates the reproducibility of the results, and highlights the potential of these technologies in biomarker discovery and disease pathology. For cells and tissues (heart, liver, lung, and intestine) proteomics analysis by data-independent acquisition mode, identifications exceeding 10,000 proteins can be achieved with a 24 min active gradient. In 200 ng injections of HeLa digest across multiple gradients, an average of more than 80% of proteins have a CV less than 20%, and a 45 min run covers ∼90% of the expressed proteome. This complete workflow allows for large swaths of the proteome to be identified and is compatible with diverse sample types.

17 December 2018 in Journal of Proteome Research
Verified
Journal Article
Closed access
Leon ReubsaetLeon Reubsaet
Leon Reubsaet
MSMichael J. Sweredoski
Michael J. Sweredoski
AMAnnie Moradian
Annie Moradian